Detalles de la búsqueda
1.
Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial.
Oncologist
; 28(12): e1259-e1267, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338150
2.
Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors.
Oncologist
; 22(6): 638-e56, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28465370
3.
[Efficacy and safety of rituximab combined with CHOP or combined with dose fractionated CHOP in the treatment of primary gastric diffuse large B cell lymphoma].
Zhonghua Zhong Liu Za Zhi
; 36(12): 939-43, 2014 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-25623771
4.
Construction and Validation of a Gastric Cancer Diagnostic Model based on Blood Groups and Tumor Markers.
J Cancer
; 15(3): 729-736, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38213731
5.
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial.
Eur J Cancer
; 199: 113539, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237373
6.
Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial.
Chin Med J (Engl)
; 136(14): 1690-1698, 2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37469024
7.
Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation.
Clin Respir J
; 17(3): 148-156, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710485
8.
Early changes in soluble intracellular adhesion molecule-1 as prognostic biomarkers to immune checkpoint inhibitor.
Clin Transl Sci
; 16(8): 1396-1407, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317057
9.
Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases.
Ann Hematol
; 91(11): 1721-9, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22733613
10.
Phase I Trial of a Novel Anti-HER2 Antibody-Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer.
Clin Cancer Res
; : OF1-OF10, 2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35766963
11.
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study.
Clin Cancer Res
; 28(4): 618-628, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844975
12.
A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers.
Target Oncol
; 16(2): 177-187, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33492568
13.
A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy.
Medicine (Baltimore)
; 99(44): e22886, 2020 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33126339
14.
[The retrospective analysis of prophylactic administration of pegylated recombinant human granulocyte colony stimulating factor in lymphoma patients undergoing chemotherapy].
Zhonghua Xue Ye Xue Za Zhi
; 35(5): 453-5, 2014 May.
Artículo
en Zh
| MEDLINE | ID: mdl-24857220
Resultados
1 -
14
de 14
1
Próxima >
>>